BeStock  
Stocks › Biotechnology › ALT

Altimmune ALT

US equityMarket cap rank #3713Biotechnology
$2.08 +$0.11 (+5.58%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $2.07 -0.48%
Open$1.97
Prev close$1.97
Day range$1.95 – $2.10
Volume2.77M
Market cap$404.60M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership77.7%-1.21 pts vs. prior quarter
Institutions holding237-5 vs. prior quarter
Insider trades (recent)38 buys / 12 sellsNet buying
Short interest21.71% of floatDays to cover 10.4 · as of 15 Oct 2026
Short-sale volume share24.4%5-day average of daily volume

Short-sale volume as % of daily volume

4%13%23%32%Sep '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$3.94M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$2.2MSuper−$1.7MBig−$4.5MMid−$4.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.6% of shares outstanding.

Largest holders

  • BlackRock10.48%
  • Deep Track Capital, LP9.90%
  • State Street Global Advisors6.22%
  • TCG Crossover Management, LLC5.14%
  • Vanguard Capital Management, LLC4.87%
  • Vanguard Portfolio Management, LLC3.77%
  • Marshall Wace LLP3.52%
  • Viking Global Investors LP3.44%

By investor type

  • Mutual Fund36.50%
  • VC/PE Fund19.37%
  • Hedge Fund18.15%
  • Public Company2.31%
  • Private Company1.06%
  • Individual/Insider0.48%
  • Insurance Company0.23%
  • Government Pension Fund0.10%

Reported short interest has fallen from 26.71% to 21.71% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Deep Track Capital, LP VC/PE Fund 2026/Q3 +19,250,000 9.9%
TCG Crossover Management, LLC VC/PE Fund 2026/Q3 +10,000,000 5.1%
BlackRock Mutual Fund 2026/Q3 +7,590,007 10.5%
Viking Global Investors LP Hedge Fund 2026/Q3 +6,700,000 3.4%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +6,500,000 3.3%
State Street Global Advisors Mutual Fund 2026/Q3 +4,952,990 6.2%
Woodline Partners LP Hedge Fund 2026/Q3 +3,400,312 1.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +2,943,386 4.9%
Marshall Wace LLP Hedge Fund 2026/Q3 +2,823,154 3.5%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +2,660,000 1.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,948,263 3.8%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +1,904,218 2.6%
Great Point Partners, LLC VC/PE Fund 2026/Q3 +1,741,232 0.9%
Weiss Asset Management, LLC Hedge Fund 2026/Q3 +1,530,803 0.8%
Nantahala Capital Management, LLC Hedge Fund 2026/Q3 +1,500,000 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 Gregory Weaver Chief Financial Officer Derivative Exercise and Sale -4,379 $2.76 49,927
30 Sep 2026 Gregory Weaver Chief Financial Officer Derivative Exercise and Retained +10,096 – 49,927
30 Sep 2026 Christophe Arbet-Engels Chief Medical Officer Derivative Exercise and Sale -12,679 $2.76 24,821
30 Sep 2026 Christophe Arbet-Engels Chief Medical Officer Derivative Exercise and Retained +24,821 – 24,821
15 Sep 2026 Linda Richardson Chief Commercial Officer Derivative Exercise and Sale -6,826 $3.24 17,174
15 Sep 2026 Linda Richardson Chief Commercial Officer Derivative Exercise and Retained +17,174 – 17,174
12 Aug 2026 Jerome Durso Chairperson & CEO Open Market Acquisition +15,000 $2.95 62,500
30 Jul 2026 Gregory Weaver Chief Financial Officer Other Acquisition +1,753 $2.41 39,831
30 Jul 2026 M. Roberts Chief Scientific Officer Other Acquisition +875 $2.41 113,699
30 Apr 2026 Mitchel Sayare Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 John Gill Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 Philip Hodges Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 Klaus Schafer Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 Catherine Sohn Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 Wayne Pisano Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 Diane Jorkasky Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
30 Apr 2026 Teri Lawver Independent Director Other Derivative Acquisition +48,800 $2.82 48,800
5 Apr 2026 John Gill Independent Director Open Market Acquisition +9,200 $3.41 21,700
31 Mar 2026 Gregory Weaver Chief Financial Officer Open Market Acquisition +10,000 $3.15 38,078
31 Mar 2026 Jerome Durso Chairperson & CEO Open Market Acquisition +15,000 $3.14 47,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Oct 2026 42,233,791 21.7% 10.4
30 Sep 2026 46,079,911 23.7% 10.5
15 Sep 2026 51,749,756 26.6% 15.4
31 Aug 2026 49,714,773 25.6% 11.8
14 Aug 2026 50,972,774 26.2% 11.0
31 Jul 2026 51,938,259 26.7% 11.5

Discussion

No comments yet — be the first to weigh in on ALT.

Sign in to join the discussion.

Scroll to Top